Latest Transpact Enterprises stock price
Transpact Enterprises P/E Ratio
TRANSPACT • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
628.04
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
628.04
Current Price
₹
EPS (TTM)
₹0.23
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.01
Sector Median
30.38
Sector Rank
#11 of 131
Sector Percentile
8.4%
Key P/E Ratio Insights for Transpact Enterprises
- Stock appears overvalued with PE of 628.04, suggesting caution for new investments
- Trading at premium to sector average PE of 49.01
View the TRANSPACT equity price for detailed stock performance.
Related Pages for Transpact Enterprises
Additional stock information and data for TRANSPACT
Sector P/E Ratio Comparison
Comparing Transpact Enterprises with other companies in Healthcare sector
Sector Average
49.01
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
515.32
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |